CIC::DUX4 リアレンジされた肉腫からの患者由来腫瘍は,治療標的としてMCL1を識別する
Willemijn Breunis1, Eva Brack2, Anna C Ehlers3,4,5,6
1Department of Oncology and Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland.
Nature communications
|August 21, 2025
まとめ
精密医療は患者の腫瘍を ex vivo でプロファイリングすることで サルコマの治療を進めています MCL1を標的とした治療は,CIC再編成型サルコマの治療に有望であり,高リスクの患者に新しい治療方法を提示しています.
科学分野:
- 腫瘍学
- 癌 生物学
- 精密医療
背景:
- ユーイング肉腫やCIC再編成肉腫のような高リスク肉腫は 予後が悪い.
- 現在進行中の集中治療は 転移や再発の症例に限られた成功を収めている.
- 精密医療とex vivo薬物プロファイリングは 新しい治療戦略を提示します
研究 の 目的:
- ユーイングおよびCIC::DUX4肉腫のex vivo腫瘍モデルを確立し,検証する.
- 患者から得られた腫瘍モデルを使って 大規模な薬物スクリーニングを行います
- CIC:: DUX4 サルコムの新たな治療標的を特定する.
主な方法:
- 患者からのサルコマ細胞の増殖が,ex vivoで腫瘍状になる.
- 腫瘍型モデルにおける元の分子および機能的特徴の維持
- 腫瘍細胞と異種移植モデルで 大規模な薬物図書館のスクリーニング
主要な成果:
- ARID1A変異を含む患者の腫瘍特性を正確に反映した.
- EwingとCIC:: DUX4サルコマの間の薬剤反応のプロファイルが異なったことが観察されました.
- CIC:: DUX4 サルコマ細胞は,CIC:: DUX4 腫瘍遺伝子の標的であるMCL1への依存を示した.
結論:
- サルコマの個別の症例では,ex vivo薬物プロファイリングが可能である.
- MCL1の阻害はアポトーシスを誘発し,CIC:: DUX4肉腫の腫瘍の成長を阻害する.
- MCL1はCIC:: DUX4肉腫の潜在的治療標的であり,臨床評価が必要である.
関連する概念動画
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.